{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-027543","form_type":"8-K","ticker":"PETV","cik":"0001512922","company_name":"PetVivo Holdings, Inc.","filed_at":"2023-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.153566+00:00","generated_at":"2026-06-11T17:19:21.109568+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"PetVivo reports Q1 net loss of $2.9M, revenue up to $117K; working capital deficit","bullets":["Revenue $117,183 vs $58,174 YoY; net loss $2,893,577 ($0.25 per share) vs $1,965,428 ($0.20) YoY.","Operating loss $2,893,577; operating expenses $2,928,491, up 49% YoY due to Spryng launch costs.","Working capital deficit $448,561 as of June 30; prior year audited financials include going concern opinion.","Raised $2,325,000 net proceeds from two August offerings: $550K convertible notes and $1.775M common stock/warrants.","Spryng used by over 450 vet clinics in 47 states; board added Spencer Breithaupt."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-027543","json":"https://secwatch.observer/filing/0001493152-23-027543.json","markdown":"https://secwatch.observer/filing/0001493152-23-027543.md","text":"https://secwatch.observer/filing/0001493152-23-027543.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512922/000149315223027543/0001493152-23-027543-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512922/000149315223027543/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T17:19:21.109568+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"def82f8a973ce9b1dc1048a84c91475b7741bd2a","claim":"PetVivo Holdings, Inc. reported three months ended June 30, 2023 results: revenue $117,183, net income $2,893,577 or ($0.25) per share, EPS ($0.25) per share.","evidence_excerpt":"university study and other third-party studies prior to including a product in their catalog of products.” First Quarter Financial Results Total Revenues . Revenues were $117,183 and $58,174 for three months ended June 30, 2023 and 2022, respectively. Revenues in the three months ended June 30, 2023, consist of sales of our SpryngTM products to MWI","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1512922/000149315223027543/0001493152-23-027543-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended June 30, 2023"},{"label":"Revenue","value":"$117,183"},{"label":"Net income","value":"$2,893,577 or ($0.25) per share"},{"label":"EPS","value":"($0.25) per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}